The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs

被引:363
|
作者
Allan, SE
Passerini, L
Bacchetta, R
Crellin, N
Dai, MY
Orban, PC
Ziegler, SF
Roncarolo, MG
Levings, MK
机构
[1] Univ British Columbia, Dept Surg, Vancouver, BC V6H 3Z6, Canada
[2] Vancouver Coastal Hlth Res Inst, Immun & Infect Res Ctr, Vancouver, BC, Canada
[3] Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy, HSR TIGET, I-20132 Milan, Italy
[4] Benaroya Res Inst Virginia Mason, Program Immunol, Seattle, WA USA
[5] Univ Vita Salute San Raffaele, Milan, Italy
来源
JOURNAL OF CLINICAL INVESTIGATION | 2005年 / 115卷 / 11期
关键词
D O I
10.1172/JCI24685
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Little is known about the molecules that control the development and function of CD4(+)CD25(+)Tregs. Recently, it was shown that the transcription factor FOXP3 is necessary and sufficient for the generation of CD4(+)CD25(+) Tregs in mice. We investigated the capacity of FOXP3 to drive the generation of suppressive CD4(+)CD25(+) Tregs in humans. Surprisingly, although ectopic expression of FOXR3 in human CD4(+) T cells resulted in induction of hyporesponsiveness and suppression of IL-2 production, it,did not lead to acquisition of significant suppressor activity in vitro. Similarly, ectopic expression of FOXP3 Delta 2, an isoform found in human CD4(+)CD25(+) Tregs that lacks exon 2, also failed to induce the development of suppressor T cells. Moreover, when FOXP3 and FOXP3 Delta 2 were simultaneously overexpressed, although the expression of several Treg-associated cell surface markers was significantly increased, only a modest suppressive activity was induced. These data indicate that in humans, overexpression of FOXP3 alone or together with FOXP3 Delta 2 is not an effective method to generate potent suppressor T cells in vitro and suggest that factors in addition to FOXP3 are required during the process of activation and/or differentiation for the development of bona fide Tregs.
引用
收藏
页码:3276 / 3284
页数:9
相关论文
共 50 条
  • [1] Role of IFN-γ in induction of Foxp3 and conversion of CD4+CD25- T cells to CD4+ Tregs
    Wang, Zhaojun
    Hong, Jian
    Sun, Wei
    Xu, Guangwu
    Li, Ningli
    Chen, Xi
    Liu, Ailian
    Xu, Lingyun
    Sun, Bing
    Zhang, Jingwu Z.
    JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (09): : 2434 - 2441
  • [2] IPEX and the role of FOXP3 in the development and function of human Tregs
    Le Bras, Severine
    Geha, Raif S.
    JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (06): : 1473 - 1475
  • [3] Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells
    Wang, Jun
    Ioan-Facsinay, Andreea
    van der Voort, Ellen I. H.
    Huizinga, Tom W. J.
    Toes, Rene E. M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (01) : 129 - 138
  • [4] Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3
    Allan, Sarah E.
    Alstad, Alicia N.
    Merindol, Natacha
    Crellin, Natasha K.
    Amendola, Mario
    Bacchetta, Rosa
    Naldini, Luigi
    Roncarolo, Maria Grazia
    Soudeyns, Hugo
    Levings, Megan K.
    MOLECULAR THERAPY, 2008, 16 (01) : 194 - 202
  • [5] Defining a role for FOXP3 in human CD4+T-cells.
    Allan, Sarah
    Passerini, Laura
    Bacchetta, Rosa
    Amendola, Mario
    Naldini, Luigi
    Roncarolo, Maria Grazia
    Levings, Megan
    CLINICAL IMMUNOLOGY, 2006, 119 : S193 - S193
  • [6] The Role of Tregs in Cancer: Foxp3 as a Putative Target for Therapy
    Meyer, Brendan
    Liu, Wai M.
    Dalgleish, Angus G.
    Galustian, Christine
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2009, 4 (02) : 122 - 129
  • [7] A modified flow cytometry method for objective estimation of human CD4+ regulatory T cells (CD4+ Tregs) in peripheral blood, via CD4/CD25/CD45RO/FoxP3 labeling
    Petsiou, Asimina
    Paschou, Stavroula A.
    Vartholomatos, Georgios
    Chatzigianni, Katerina
    Kolaitis, Nikolaos
    Giotaki, Eleni
    Bondinas, George P.
    Moustakas, Antonis K.
    Karamoutsios, Achilleas
    Zervou, Eleftheria
    Tigas, Stelios
    Tsatsoulis, Agathocles
    Papadopoulos, George K.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2020, 98 (03) : 259 - 269
  • [8] Splice variants of human FOXP3 are functional inhibitors of human CD4+ T-cell activation
    Smith, Emma L.
    Finney, Helene M.
    Nesbitt, Andrew M.
    Ramsdell, Fred
    Robinson, Martyn K.
    IMMUNOLOGY, 2006, 119 (02) : 203 - 211
  • [9] Cannabidiol (CBD) induces functional CD4+ CD25+ FOXP3+ Tregs
    Dhital, Saphala
    Park, Nogi
    Seo, Keun Seok
    Kaplan, Barbara L. F.
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [10] Low-Dose Antigen Promotes Induction of FOXP3 in Human CD4+ T Cells
    Long, S. Alice
    Rieck, Mary
    Tatum, Megan
    Bollyky, Paul L.
    Wu, Rebecca P.
    Muller, Isabelle
    Ho, Jhon-Chun
    Shilling, Heather G.
    Buckner, Jane H.
    JOURNAL OF IMMUNOLOGY, 2011, 187 (07): : 3511 - 3520